Index of reports
> Cases with Foetal Exposure During Pregnancy (128)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Norvir (Ritonavir) where reactions include foetal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 128 Next >>
Possible Norvir side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Foetal Chromosome Abnormality, Spina Bifida, Foetal Exposure During Pregnancy, Arnold-Chiari Malformation, Vertical Talus
Drug(s) suspected as cause:
Truvada
Dosage: 1 df, unk
Start date: 2011-07-13
End date: 2011-10-27
Reyataz
Dosage: 300 mg, qd
Start date: 2011-07-13
End date: 2011-10-27
Combivir
Dosage: 2 df, unk
Start date: 2011-11-21
Norvir
Dosage: 100 mg, qd
Start date: 2011-07-13
End date: 2011-10-27
Isentress
Dosage: 800 mg, qd
Start date: 2011-11-21
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male
Reactions: Congenital Bladder Anomaly, Urethral Valves, Congenital Hydronephrosis, Foetal Exposure During Pregnancy, Bladder Obstruction, Congenital Renal Disorder
Drug(s) suspected as cause:
Lisinopril
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Atorvastatin
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a physician from United States on 2012-08-24
Patient: male, weighing 2.0 kg (4.4 pounds)
Reactions: Hyperbilirubinaemia, Premature Baby, Foetal Exposure During Pregnancy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Norvir
Other drugs received by patient: Intelence; Epzicom; Prezista; Truvada; Intelence
Possible Norvir side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male, weighing 2.6 kg (5.7 pounds)
Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Other drugs received by patient: Combivir; Zidovudine; Darunavir Ethanolate
Possible Norvir side effects in
Reported by a physician from United States on 2012-08-23
Patient: , weighing 1.9 kg (4.2 pounds)
Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation
Drug(s) suspected as cause:
Norvir
Dosage: 100mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Truvada
Dosage: 1tab per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Combivir
Dosage: 2tab per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Raltegravir
Dosage: 800mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Reyataz
Dosage: 300mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Possible Norvir side effects in male
Reported by a physician from France on 2012-08-21
Patient: male
Reactions: Dysmorphism, Foetal Exposure During Pregnancy, Renal Dysplasia, Intestinal Malrotation, Persistent Cloaca, Trisomy 21, Bladder Dilatation, Cleft Palate, Protrusion Tongue, Renal Aplasia, LOW SET Ears, Abdominal Distension, Anal Atresia, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from Portugal on 2012-08-21
Patient: male
Reactions: Pneumonia, Foetal Exposure During Pregnancy, Respiratory Distress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Truvada
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Prezista
Indication: Maternal Exposure Timing Unspecified
Isentress
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: male, weighing 3.7 kg (8.2 pounds)
Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Combivir
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a physician from United States on 2012-08-17
Patient: male, weighing 3.7 kg (8.1 pounds)
Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis
Drug(s) suspected as cause:
Truvada
Dosage: 1tab per day
Indication: Antiretroviral Therapy
End date: 2011-11-10
Combivir
Dosage: 2tab per day
Indication: Antiretroviral Therapy
Start date: 2011-11-10
End date: 2012-06-07
Norvir
Dosage: 100mgd per day
Indication: Antiretroviral Therapy
Reyataz
Dosage: 300mgd per day
Indication: Antiretroviral Therapy
Other drugs received by patient: Retrovir; Fluconazole; Terazol Cream; Retrovir; Unspecified Medication
Possible Norvir side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: female, weighing 3.7 kg (8.1 pounds)
Reactions: Neurofibromatosis, Foetal Exposure During Pregnancy, Cafe AU Lait Spots
Drug(s) suspected as cause:
Truvada
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Possible Norvir side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient:
Reactions: Foetal Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in female
Reported by a physician from France on 2012-08-17
Patient: female
Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault
Adverse event resulted in: death
Drug(s) suspected as cause:
Truvada
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15
Patient: female
Reactions: Foetal Exposure During Pregnancy, Congenital Genital Malformation Female
Drug(s) suspected as cause:
Prezista
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient:
Reactions: Hypoplastic Left Heart Syndrome, Foetal Exposure During Pregnancy, Stillbirth, Heart Disease Congenital
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Product Used FOR Unknown Indication
Possible Norvir side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient:
Reactions: Cytogenetic Abnormality, Premature Baby, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation, Cerebral Haemorrhage, Genetic Polymorphism
Adverse event resulted in: death
Drug(s) suspected as cause:
Truvada
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: male, weighing 2.7 kg (5.9 pounds)
Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy
Adverse event resulted in: death
Drug(s) suspected as cause:
Kaletra
Dosage: unk
Indication: Maternal Exposure During Pregnancy
Start date: 2011-04-21
End date: 2011-04-28
Norvir
Dosage: 100 mg/day
Start date: 2011-05-11
Prezista
Dosage: 800 mg/day
Indication: Maternal Exposure During Pregnancy
Start date: 2011-04-28
Zidovudine
Dosage: 2.0 mg/day
Indication: Maternal Exposure During Pregnancy
Start date: 2011-09-15
End date: 2011-09-15
Norvir
Dosage: 200 mg/day
Indication: Maternal Exposure During Pregnancy
Start date: 2011-04-28
End date: 2011-05-10
Combivir
Dosage: unk
Indication: Maternal Exposure During Pregnancy
Start date: 2011-04-21
End date: 2011-09-15
Possible Norvir side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Foetal Chromosome Abnormality, Spina Bifida, Foetal Exposure During Pregnancy, Arnold-Chiari Malformation, Vertical Talus
Drug(s) suspected as cause:
Truvada
Dosage: 1 df, unk
Start date: 2011-07-13
End date: 2011-10-27
Combivir
Dosage: 2 df, unk
Start date: 2011-11-21
Norvir
Dosage: 100 mg, qd
Start date: 2011-07-13
End date: 2011-10-27
Reyataz
Dosage: 300 mg, qd
Start date: 2011-07-13
End date: 2011-10-27
Isentress
Dosage: 800 mg, qd
Start date: 2011-11-21
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: male
Reactions: Urethral Valves, Congenital Bladder Anomaly, Congenital Hydronephrosis, Foetal Exposure During Pregnancy, Bladder Obstruction, Congenital Renal Disorder
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09
Patient: male, weighing 3.1 kg (6.8 pounds)
Reactions: Foetal Exposure During Pregnancy, Naevus Flammeus
Drug(s) suspected as cause:
Truvada
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09
Patient: male, weighing 3.1 kg (6.8 pounds)
Reactions: Foetal Exposure During Pregnancy, Naevus Flammeus
Drug(s) suspected as cause:
Truvada
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a physician from United States on 2012-08-09
Patient: male, weighing 2.6 kg (5.7 pounds)
Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Other drugs received by patient: Darunavir Ethanolate; Zidovudine; Combivir
Possible Norvir side effects in male
Reported by a physician from France on 2012-08-08
Patient: male
Reactions: Foetal Exposure During Pregnancy, Haemangioma Congenital
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08
Patient: male, weighing 2.7 kg (5.9 pounds)
Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy
Drug(s) suspected as cause:
Zidovudine
Dosage: 2mgd per day
Indication: Prophylaxis
Start date: 2011-09-15
End date: 2011-09-15
Norvir
Dosage: 200mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-04-28
End date: 2011-05-10
Combivir
Dosage: 2tab per day
Indication: Antiretroviral Therapy
Start date: 2011-04-21
End date: 2011-09-15
Prezista
Dosage: 800mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-04-28
Norvir
Dosage: 100mgd per day
Start date: 2011-05-11
Kaletra
Dosage: 4tab per day
Indication: Antiretroviral Therapy
Start date: 2011-04-21
End date: 2011-04-28
Possible Norvir side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient: , weighing 1.9 kg (4.2 pounds)
Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation
Drug(s) suspected as cause:
Truvada
Dosage: 1tab per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Reyataz
Dosage: 300mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Combivir
Dosage: 2tab per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Raltegravir
Dosage: 800mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Norvir
Dosage: 100mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient: male, weighing 3.1 kg (6.8 pounds)
Reactions: Foetal Exposure During Pregnancy, Naevus Flammeus
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient: male
Reactions: Urethral Valves, Congenital Bladder Anomaly, Congenital Hydronephrosis, Foetal Exposure During Pregnancy, Bladder Obstruction, Congenital Renal Disorder
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a physician from France on 2012-08-03
Patient: male
Reactions: Foetal Exposure During Pregnancy, Haemangioma Congenital
Drug(s) suspected as cause:
Reyataz
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in female
Reported by a pharmacist from Canada on 2012-08-03
Patient: female
Reactions: Microcephaly, Foetal Exposure During Pregnancy, Infantile Spasms
Drug(s) suspected as cause:
Norvir
Indication: Product Used FOR Unknown Indication
Truvada
Indication: Product Used FOR Unknown Indication
Reyataz
Indication: Product Used FOR Unknown Indication
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: male, weighing 3.1 kg (6.8 pounds)
Reactions: Foetal Exposure During Pregnancy, Naevus Flammeus
Drug(s) suspected as cause:
Reyataz
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Norvir side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: male, weighing 3.7 kg (8.2 pounds)
Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Combivir
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Page 1 Next >>
|